Familial severe congenital neutropenia associated with infantile osteoporosis: A new entity

American Journal of Hematology

Volumn 72, Issue 1, 2003, Pages 34-37

  Elhasid, R ^a   Hofbauer, L C ^c   Ish Shalom, S ^a   Ben Arush, M ^a   Koc, O ^d   Rowe, J M ^b   Etzioni, Amos ^a,b  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Immunodeficiency; Neutropenia; Osteoporosis

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ARTICLE; BONE MARROW BIOPSY; BONE REMODELING; CASE REPORT; CELL MATURATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILIAL DISEASE; FAMILY; FEMUR FRACTURE; FRACTURE; HOSPITALIZATION; HUMAN; JUVENILE OSTEOPOROSIS; MALE; NEUTROPENIA; OSTEOPOROSIS; PEDIGREE; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE;

AGAMMAGLOBULINEMIA; BONE REMODELING; CARRIER PROTEINS; CELLS, CULTURED; CHILD, PRESCHOOL; CONSANGUINITY; FAILURE TO THRIVE; FIBROBLASTS; FILGRASTIM; FRACTURES, SPONTANEOUS; GENES, RECESSIVE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MEMBRANE GLYCOPROTEINS; NEUTROPENIA; OSTEOPOROSIS; OSTEOPROTEGERIN; PANCYTOPENIA; PEDIGREE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RECURRENCE;

EID: 0037222694     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10261     Document Type: Article

References (16)

1. Hong R. Association of the skeletal and immune systems. Am J Med Genet 1989;34:55-59.
2. Koc O, Gerson S, Cooper B, Dyhouse S, Haynesworth S, Caplan A, Lazarus HM. Rapid hematopoietic recovery after co-infusion of autologous culture-expanded human mesenchymal stem cells (hMSCs) and PBSCs in breast cancer patients receiving high dose chemotherapy. J Clin Oncol 1998;92:274a.
3. Khosla S. The OPG/RANKL/RANK system. Endocrinology 2001;142;5050-5056.
4. Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD. Osteoprotegerin serum levels in men: Correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 2001;86:3162-3165.
5. Yakisan E, Schirg E, Zeidler C, Bishop NJ, Reiter A, Hirt A, Riehm H, Welte K. High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome). J Pediatr 1997;131:592-597.
6. Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. Semin Hematol 2002;39:82-88.
7. Sekhar RV, Culbert S, Hoots WK, Klein MJ, Zietz H, Vassilopoulou-Sellin R. Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: Suggested therapeutic approach. Pediatrics 2001;108:E54.
8. Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, Boxer LA, Kannourakis G, Zeidler C, Welte K, Benson KF, Horwitz M. Mutation in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000;96:2317-2122.
9. Zeidler C, Welte K, Barak Y, Barriga F, Bolyard AA, Boxer L, Cornu G, Cowan MJ, Dale DC, Flood T, Freedman M, Gadner H, Mandel H, O'Reilly RJ, Ramenghi U, Reiter A, Skinner R, Vermylen C, Levine JE. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000;95:1195-1198.
10. Lee PJ, Patel JS, Fewtrell M, Leonard JV, Bishop NJ. Bone mineralisation in type 1 glycogen storage disease. Eur J Pediatr 1995;154:483-487.
11. Papadaki HA, Margioris AN, Miliaki M, Steriopoulos C, Valatas W, Eliopoulos GD. Chronic idiopathic neutropenia of adults is associated with decreased bone mineral density and alterations in bone turnover biochemical markers. Eur J Haematol 1999;62:311-316.
12. Arron JR, Choi Y. Bone versus immune system. Nature 2000;408:535-536.
13. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and INF-γ. Nature 2000;408:600-605.
14. Hofbauer LC, Neubauer A, Heufelder AE. Receptor activator of nuclear factor κ-B ligand and osteoprotegerin. Cancer 2001;92:460-470.
15. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HO, Wooden S, Campbell P, Boyle WJ, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
16. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12:1260-1268.